Gilteritinib 40 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 40 mg

Reference Brands: Xospata (USA)

Category: Oncology Cancer Care

Gilteritinib is a Oncology Cancer Care product available as Tablets in strengths 40 mg. It corresponds to the reference brand Xospata (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Gilteritinib is a targeted anticancer medication used in the treatment of acute myeloid leukemia (AML), one of the most common types of leukemia in adults. AML is often associated with a poor prognosis, especially in patients whose disease has relapsed or does not respond to initial treatment. A significant proportion of AML patients carry a mutation in the FMS-like tyrosine kinase 3 (FLT3) gene, which leads to increased cancer cell growth and reduced cellular differentiation, contributing to the aggressive nature of the disease.

Gilteritinib is a second-generation FLT3 inhibitor designed to specifically target and block the activity of the FLT3 receptor. By inhibiting this signaling pathway, the drug helps slow the proliferation of leukemia cells and supports better disease control. It is primarily indicated for adult patients with relapsed or refractory AML who test positive for an FLT3 mutation using an approved diagnostic test.

Approved by the U.S. Food and Drug Administration (FDA), Gilteritinib represents an important advancement in targeted therapy for AML. It is marketed under the brand name Xospata and is administered orally in tablet form. The drug has shown improved clinical outcomes compared to conventional therapies in patients with FLT3-mutated AML.